Lori Shogren

As interest from the pharmaceutical industry in developing drugs to treat Ataxia continues to grow, we at the National Ataxia Foundation believe that collaboration among researchers, clinicians, pharmaceutical companies, and Ataxia patients has reached a critical moment. Each of these groups must work together, as partners, to advance progress toward better patient care and more effective treatments for Ataxia. The time is now!
Join us in Denver at the 63rd Annual Ataxia Conference to learn, share, network, and have fun.

From: 03/06/2020 - To: 03/07/2020

All day event

Denver, Colorado, United States of America

Featured Speakers

Jeremy Schmahmann, MD
Professor of Neurology at Harvard Medical School and Neurologist at the Massachusetts General Hospital
The Keynote Address “Your Voice in Drug and Therapy Development” will be delivered by the prominent Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical School, and a Neurologist at Massachusetts General Hospital where he is Founding Director of the Ataxia Unit.